Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
55 /100
HIGH RISK
Score updated Oct 13, 2026

TTRX — Turn Therapeutics Inc. Dilution Risk Tracker

Track TTRX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track TTRX — Get alerts when the score changes →

As of October 13, 2026, Turn Therapeutics Inc. (TTRX) has a DilutionWatch DilutionScore of 55/100, rated HIGH dilution risk. Turn Therapeutics Inc. has a market capitalization of $330.95M, 29.79M shares outstanding, 20 institutional holders tracked. Stored dilution-related fields include 1.19M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
25
📊 Float Risk
65
⚠️ Warrant Exposure
15
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 7%
📉 Score Deterioration model 15%
• Score climbed 7 points (worsening)
🔔 Track TTRX — Get forecast alerts →

Market Data

Market Cap$330.95M
Shares Outstanding29.79M
Float11.13M
Cash$9.95M
Debt$6.06M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore55/100DilutionWatch score record
Shares Outstanding29.79MVerified float table or market cache
Public Float11.13MVerified float table or market cache
Market Cap$330.95MMarket data cache
Cash Runway23.4 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants1.19MSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 6.

Recent SEC source mix: 4 4, EFFECT 1, XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 11.9% shares (2026Q1 vs prior)
20 institutional holders · 521.8K shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 98.9K shares
#2 DDFG, Inc 70.5K shares
#3 MILLENNIUM MANAGEMENT LLC 69.8K shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest268.8K
Days to Cover1.3
% of Float2.4%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-08-12
4 INSIDER TRANSACTION 2026-04-03
4 INSIDER TRANSACTION 2026-04-03
4 INSIDER TRANSACTION 2026-04-03
4 INSIDER TRANSACTION 2026-04-03
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual TTRX Dilution Snapshot

Turn Therapeutics Inc. (TTRX) has a DilutionScore of 55/100, rated High dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

TTRX's DilutionScore is currently 55/100 (High risk), with 3 score changes tracked over 89 days. The score improved from 48/100 (Medium risk).

Period Score Risk Level Duration
Oct 13, 202655/100HIGH1 day
Aug 22 – Oct 12, 202648/100MEDIUM52 days
Aug 14 – Aug 21, 202651/100HIGH7 days
Jul 16 – Aug 13, 202648/100MEDIUM29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

TTRX shares outstanding have decreased 0.0% from 29.79M (Apr 2026) to 29.79M (Apr 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
Apr 11, 202629.79M11.13M▲ 1.99%
Apr 09, 202629.79M10.91M▲ 4.06%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track TTRX Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment TTRX files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking TTRX — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for TTRX
TTRX FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.